Investor List:

Top Medical Devices Series B Investors in Seattle / Portland (12)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Medical Devices investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Mark Knittel, President at Bellingham Angels (Bellingham Angel Investors)
Mark Knittel
Sweet spot: $138K
Range: $25K - $250K
Investors in Bellingham (WA)
Investors in Medical Devices (Seed), Investors in SMB Software (Seed), Investors in ClimateTech/CleanTech (Series B), Investors in Entertainment & Sports (Seed), Investors in Entertainment & Sports (Series B), Investors in EnergyTech (Series B), Investors in Entertainment & Sports (Series A), Investors in Media/Content (Seed), Investors in ClimateTech/CleanTech (Series A), Investors in EnergyTech (Seed), Investors in EnergyTech (Series A), Investors in ClimateTech/CleanTech (Seed), Investors in Medical Devices (Series B), Investors in Media/Content (Series B), Investors in Medical Devices (Series A), Investors in Media/Content (Series A), Investors in SMB Software (Series B), Investors in SMB Software (Series A), Investors in Seattle / Portland (Other Lists), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in ClimateTech/CleanTech (Seed), Investors in EnergyTech (Seed), Investors in Entertainment & Sports (Seed), Investors in Health IT (Seed), Investors in Media/Content (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in SMB Software (Seed), Investors in Health & Hospital Services (Seed), Investors in ClimateTech/CleanTech (Series A), Investors in Entertainment & Sports (Series A), Investors in EnergyTech (Series A), Investors in Health IT (Series A), Investors in Media/Content (Series A), Investors in Medical Devices (Series A), Investors in SMB Software (Series A), Investors in Health & Hospital Services (Series A), Investors in ClimateTech/CleanTech (Series B), Investors in Media/Content (Series B), Investors in Medical Devices (Series B), Investors in EnergyTech (Series B), Investors in Entertainment & Sports (Series B), Investors in Health IT (Series B), Investors in SMB Software (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Nathan McDonald, Managing Partner at Keiretsu Capital
Nathan McDonald
Keiretsu Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Seattle (WA)
Investors in Medical Devices (Seed), Investors in Hardware (Seed), Investors in Pharmaceuticals (Seed), Investors in Media/Content (Seed), Investors in Hardware (Series B), Investors in Consumer Internet (Series B), Investors in Medical Devices (Series B), Investors in Media/Content (Series B), Investors in Cosmetics (Series B), Investors in Pharmaceuticals (Series B), Investors in Cosmetics (Seed), Investors in Seattle / Portland (Other Lists), Investors in Consumer Internet (Seed), Investors in Hardware (Seed), Investors in Media/Content (Seed), Investors in Medical Devices (Seed), Investors in Consumer Internet (Seed), Investors in Pharmaceuticals (Seed), Investors in Cosmetics (Seed), Investors in Consumer Internet (Series B), Investors in Media/Content (Series B), Investors in Medical Devices (Series B), Investors in Hardware (Series B), Investors in Pharmaceuticals (Series B), Investors in Cosmetics (Series B)
Photo of Loretta Little, Managing Director at WRF Capital
Loretta Little
WRF Capital·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Seattle (WA)
Investors in Medical Devices (Seed), Investors in SMB Software (Seed), Investors in BioTech (Series B), Investors in Consumer Internet (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in SMB Software (Series B), Investors in SMB Software (Series A), Investors in Seattle / Portland (Other Lists), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Seed), Investors in Consumer Internet (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in Consumer Internet (Seed), Investors in SMB Software (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Consumer Internet (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series B), Investors in SMB Software (Series A), Investors in Health & Hospital Services (Series A), Investors in Consumer Internet (Series B), Investors in Medical Devices (Series B), Investors in Health IT (Series B), Investors in SMB Software (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Consumer Internet (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Leen Kawas, General Partner at Propel Bio Partners
Leen Kawas
Propel Bio Partners·General Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Seattle (WA)
Photo of Jonathan Lim, Venture Partner at ARCH Venture Partners
Jonathan Lim
ARCH Venture Partners·Venture Partner
Sweet spot: $25.0M
Range: $50K - $50.0M
Investors in Dublin (Ireland), Investors in San Francisco (CA), Investors in Seattle (WA), Investors in Chicago (IL)
Investors in Medical Devices (Seed), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Seattle / Portland (Other Lists), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Health IT (Series A), Investors in BioTech (Series B), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Consumer Health (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Midwest (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Sabah Oney, Venture Partner at ARCH Venture Partners
Sabah Oney
ARCH Venture Partners·Venture Partner
Sweet spot: $150K
Range: $100K - $5.0M
Investors in Chicago (IL), Investors in Dublin (Ireland), Investors in San Francisco (CA), Investors in Seattle (WA)
Investors in Medical Devices (Seed), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Seattle / Portland (Other Lists), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Health IT (Series A), Investors in BioTech (Series B), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Consumer Health (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Midwest (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Jake Bauer, Venture Partner at ARCH Venture Partners
Jake Bauer
ARCH Venture Partners·Venture Partner
Sweet spot: $25.0M
Range: $50K - $50.0M
Investors in San Francisco (CA), Investors in Chicago (IL), Investors in Dublin (Ireland), Investors in Seattle (WA)
Investors in Medical Devices (Seed), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Seattle / Portland (Other Lists), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Health IT (Series A), Investors in BioTech (Series B), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Consumer Health (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Midwest (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Ari Nowacek, Principal at ARCH Venture Partners
Ari Nowacek
Sweet spot: $25.0M
Range: $50K - $150.0M
Investors in Seattle (WA)